Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs NVS✓SelectedUSD · NVSGSK vs NVS performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs NVS

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+459.7%
NVS return
+1,228.5%
Excess return
-768.8%
Maximum drawdown
-51.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioNVSExcessAlpha
1D-1.3%-2.5%+1.1%+0.1%
7D-3.1%-3.2%+0.1%-1.3%
30D-0.9%+3.3%-4.2%-2.8%
3M-4.2%+0.4%-4.6%-5.3%
6M-1.6%+4.1%-5.7%-4.6%
YTD+2.6%+16.0%-13.4%-6.5%
1Y+6.2%+24.9%-18.7%-7.3%
3Y+55.0%+81.4%-26.4%+9.0%
5Y+42.8%+128.3%-85.5%-12.5%
10Y+102.1%+253.5%-151.4%-4.2%
All+459.7%+1,228.5%-768.8%+27.8%

Cumulative growth

Daily Returns

Daily percentage return beside NVS.

Daily Out/Under-Performance

Portfolio return minus NVS return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × NVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded NVS wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling